Table 1.
Baseline characteristics of CKD patients
| Variables | Paroxetine | Agomelatine | p-value |
|---|---|---|---|
| n | 49 | 50 | – |
| Age (years) | 51.43 (9.38) | 52.60 (9.55) | 0.54 |
| Education (years) | 8.31 (3.08) | 8.22 (2.89) | 0.87 |
| Duration of CKD (years) | 2.79 (0.85) | 2.75 (0.81) | 0.81 |
| BMI (kg/m2) | 22.98 (3.21) | 22.61 (3.53) | 0.58 |
| Female/male | 20/29 | 18/32 | 0.62 |
| Single household (Y/N) | 12/37 | 14/36 | 0.69 |
| Smoking (Y/N) | 15/34 | 21/29 | 0.24 |
| Alcohol abuse (Y/N) | 5/44 | 9/41 | 0.27 |
| Diabetes mellitus (Y/N) | 30/19 | 28/22 | 0.60 |
| CKD by stage (2/3/4) | 12/27/10 | 10/29/11 | 0.86 |
| HDRS scores | 23.61 (2.86) | 23.62 (2.95) | 0.98 |
| HARS scores | 18.73 (3.06) | 18.46 (3.54) | 0.68 |
| ADL scores | 28.20 (5.40) | 28.06 (6.84) | 0.91 |
Note: Data shown as mean (standard deviation) unless indicated otherwise.
Abbreviations: CKD, chronic kidney disease; BMI, body mass index; HDRS, Hamilton Depression Rating Scale; HARS, Hamilton Anxiety Rating Scale; ADL, Activities of Daily Living.